Published 3 days ago • loading... • Updated 1 day ago

New vaccine shows promise for treating one of the deadliest forms of cancer

Personalized mRNA vaccines are showing promise in treating pancreatic cancer, with a phase 1 clinical trial published in Nature finding effectiveness among participants.
Only about 10% of people diagnosed with pancreatic cancer survive more than five years, highlighting the need for better treatment options.
The trial included 16 patients, with eight responding to the vaccine, suggesting significant immune system activation against cancer cells.
Only two patients who responded experienced cancer recurrence after three years, compared to seven of the eight non-responders.

Insights by Ground AI

Does this summary seem wrong?

14 Articles

All

Left

Center

Right

Fox News

Experimental vaccine for common cancer shows potential in clinical trial

A vaccine for pancreatic cancer could serve as a promising new therapy.At Memorial Sloan Kettering Cancer Center (MSK) in New York, an experimental approach to treating the cancer with a messenger RNA (mRNA)-based therapeutic vaccine "continues to show potential" in reducing the risk of the disease returning after surgery, according to a press release.Results from the phase 1 clinical trial, published in the journal Nature, revealed that the vac…

1 day ago·New York, United States

Read Full Article

Straight Arrow News

New vaccine shows promise for treating one of the deadliest forms of cancer

Researchers say the results of a phase 1 trial of an mRNA vaccine aimed at preventing pancreatic cancer show promise. In the trial, the vaccine prevented the cancer from coming back in patients who had already received treatment for up to three years. Pancreatic cancer is one of the deadliest forms of the disease because symptoms don't usually appear until it's in its later stages. Researchers are now looking to see how effective the vaccine is …

2 days ago

Read Full Article

NBC News

mRNA vaccines show promise in pancreatic cancer in early trial

Personalized mRNA vaccines show promise as a pancreatic cancer treatment, according to a small, early stage trial published Wednesday.

3 days ago·United States

Read Full Article

CBS News

Vaccine targeting pancreatic cancer shows promise in new study of clinical trial

A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage pancreatic cancer patients.

3 days ago

Read Full Article

SuperHits 103.7 COSY-FM

+6 Reposted by 6 other sources

Personal vaccine may reduce risk of pancreatic cancer returning after surgery, small study finds

ER Productions Limited/Getty Images (NEW YORK) — A personalized mRNA vaccine may reduce the risks of pancreatic cancer returning after surgery, according to a preliminary study published Wednesday in the journal Nature. Pancreatic cancer is one of the most aggressive cancers, with a typical survival rate of only about a year after the diagnosis according to the study. While the findings are encouraging, the vaccine is still in early testing and …

2 days ago

Read Full Article

WBAL

Personal vaccine may reduce risk of pancreatic cancer returning after surgery, study finds

A personalized mRNA vaccine may reduce the risks of pancreatic cancer returning after surgery, according to a preliminary study published Wednesday in the journal Nature. Pancreatic cancer is one of the most aggressive cancers, with a typical survival rate of only about a year after the diagnosis according to the study. While the findings are encouraging, the vaccine is still in early testing and will likely take years before it becomes widely a…

2 days ago·Baltimore, United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year